BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2481549)

  • 1. [Virus safety of fresh frozen plasma].
    Sugg U
    Beitr Infusionsther; 1989; 24():56-9. PubMed ID: 2481549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inactivation of viruses which can potentially contaminate blood products.
    Horowitz B
    Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
    Gürtler L
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral infections transmitted by blood and its products.
    Barbara JA; Tedder RS
    Clin Haematol; 1984 Oct; 13(3):693-707. PubMed ID: 6094064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of infection caused by homologous blood transfusion].
    Kühnl P; Löliger C; Laufs R
    Chirurg; 1994 Dec; 65(12):1071-4. PubMed ID: 7851137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infections as complications of blood transfusion]].
    Kłos M
    Przegl Epidemiol; 2001; 55 Suppl 3():4-9. PubMed ID: 11984956
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of transmission of viruses in the dental office.
    McCarthy GM
    J Can Dent Assoc; 2000 Nov; 66(10):554-5, 557. PubMed ID: 12584777
    [No Abstract]   [Full Text] [Related]  

  • 12. [Residual risk of infections transmitted by blood component transfusion].
    Couroucé AM
    Rev Epidemiol Sante Publique; 1994; 42(5):463-6. PubMed ID: 7973006
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of virus transmission by tissue, blood, and plasma products.
    Lelie PN; Zaaijer HL; Cuypers HT
    Transplant Proc; 1996 Oct; 28(5):2939. PubMed ID: 8908132
    [No Abstract]   [Full Text] [Related]  

  • 16. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-transmitted infectious diseases.
    Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
    Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new procedure for decreasing transfusion risk in administration of fresh frozen plasma].
    Tryba M
    Anaesthesist; 1989 Oct; 38(10):553-4. PubMed ID: 2511780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.